Time course of contrast enhancement patterns after Gd-BOPTA in correlation to myocardial infarction and viability: A feasibility study

Journal of Magnetic Resonance Imaging

Volumn 14, Issue 6, 2001, Pages 789-794

  Sandstede, Joern J W ^a   Beer, Meinrad ^a   Lipke, Claudia ^a   Pabst, Thomas ^a   Kenn, Werner ^a   Harre, Kerstin ^a   Neubauer, Stefan ^b   Hahn, Dietbert ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Cardiac imaging; Contrast agents; Heart ischemia; MR; MR contrast enhancement; Myocardial viability; Myocaridal infarction

Indexed keywords

GADOBENIC ACID;

ADULT; AGED; ARTICLE; CELL VIABILITY; CINEANGIOCARDIOGRAPHY; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CORRELATION FUNCTION; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DOSE TIME EFFECT RELATION; FEMALE; FOLLOW UP; HEART INFARCTION; HEART LEFT VENTRICLE WALL MOTION; HEART MUSCLE REVASCULARIZATION; HUMAN; MALE; PRIORITY JOURNAL; SCAR FORMATION;

ADULT; AGED; CONTRAST MEDIA; FEASIBILITY STUDIES; FEMALE; HUMANS; IMAGE ENHANCEMENT; MAGNETIC RESONANCE IMAGING, CINE; MALE; MEGLUMINE; MIDDLE AGED; MYOCARDIAL INFARCTION; ORGANOMETALLIC COMPOUNDS; TIME FACTORS;

EID: 0035185831     PISSN: 10531807     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmri.10007     Document Type: Article

References (21)

1. Myocardial infarct size after reperfusion therapy: Assessment with Gd-DTPA-enhanced MR imaging
2. Gadolinium chelates with weak binding to serum proteins
3. Alterations in T1 of normal and reperfused infarcted myocardium after Gd-BOPTA versus Gd-DTPA on inversion recovery EPI
4. Gadobenate dimeglumine (Gd-BOPTA). An overview
5. Assessment of acute myocardial infarction in man with magnetic resonance imaging and the use of a new paramagnetic contrast agent gadolinium-BOPTA
6. Analysis of first-pass and delayed MRI contrast enhancement patterns of dysfunctional myocardium for the prediction of myocardial viability
7. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction
8. Soluble-type hepatobiliary contrast agents for MR imaging
9. Current status and future perspectives of research for new MR contrast media
10. Interim results of phase II clinical testing of gadobenate dimeglumine
11. Microvascular permeability characteristics of the isolated perfused ischemic rat heart
12. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function
13. Contrast magnetic resonance imaging in the assessment of myocardial viability in patients with stable coronary artery disease and left ventricular dysfunction
14. Regional heterogeneity of human myocardial infarcts demonstrated by contrast-enhanced MRI. Potential mechanisms
15. The infarcted myocardium: Simply dead tissue, or a lively target for therapeutic interventions
16. Magnetic resonance characterization of the peri-infarction zone of reperfused myocardial infarction with necrosis-specific and extracellular nonspecific contrast media
17. The "reflow" phenomenon after temporary coronary occlusion in the dog
18. Quantification and time course of microvascular obstruction by contrast-enhanced echocardiography and magnetic resonance imaging following acute myocardial infarction and reperfusion
19. Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction
20. Contrast enhanced and functional magnetic resonance imaging for the detection of viable myocardium after infarction
21. An improved MR imaging technique for the visualization of myocardial infarction